Pancreatic cancer is a difficult disease to treat, and scientists are looking for new ways to help. A recent review looked at several mRNA vaccine candidates designed to fight this illness. These vaccines use tiny pieces of cancer proteins to train the immune system to attack tumors. The analysis found that some targets, like ADAM9 and PAK2, are highly active in these tumors and linked to how they grow and spread. Other targets, such as SCP-1 and GAGE, are found mostly in cancer cells, making them good candidates for a vaccine that won't hurt healthy tissue. Some proteins might even help the immune system kill tumors more effectively by triggering specific cell death processes. However, the review noted that many of these ideas come from lab studies or public data, not from testing on real patients yet. Because most designs use only one target or are too personalized, it is hard to make them work for everyone. Some targets also appear in normal body parts, which could cause side effects. While this research offers a clear path for future vaccine design, we must wait for clinical trials to see if these ideas truly help people.
Systematic review identifies 16 mRNA vaccine antigens for pancreatic cancer immunotherapyNew mRNA vaccine targets show promise for pancreatic cancer treatment
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider these 16 antigens as potential targets for mRNA vaccine development in pancreatic cancer, but clinical trial data are lacking.
This systematic review evaluates the potential of 16 mRNA vaccine candidate antigens (ADAM9, WNT7A, TMOD3, MET, EFNB2, TPX2, AGPS, OSBPL9, KDM5A, NRAS, SCP-1, GAGE, RAB5A, ANO6, CHMP2B, and PAK2) for pancreatic cancer immunotherapy. The review synthesizes evidence from experimental studies and public databases, focusing on antigen expression, tumor specificity, and immunogenic potential.
Key findings indicate that ADAM9 and PAK2 are highly expressed in pancreatic cancer and strongly associated with tumor proliferation, invasion, and immune regulation. SCP-1 and GAGE, as cancer–testis antigens, demonstrate high tumor specificity and immunogenic potential. Additionally, KDM5A and ANO6 may enhance antitumor efficacy through modulation of ferroptosis or pyroptosis.
The authors note several limitations: most candidates rely on single antigens or highly individualized designs, limiting scalability and broader clinical applicability. Several candidates remain constrained by normal tissue expression or limited mechanistic evidence. Importantly, claims of efficacy are based on experimental studies and public database evidence, not clinical trial outcomes.
This review offers guidance for future multi-antigen vaccine design and translational immunotherapy in pancreatic cancer, but clinical validation is needed before any practice recommendations can be made.
What this means for you:
New vaccine targets show promise for pancreatic cancer, but more testing is needed. More on Cancer
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Fibromyalgia as an oncology comorbidity increases symptom burden and impairs treatment adherence
Fibromyalgia makes managing cancer pain more difficult for patients
This systematic review of 11 studies examines fibromyalgia as a comorbidity in cancer patients. The findings indicate that fibromyalgia cont…
Patients with both fibromyalgia and cancer face higher symptom burdens and may stop life-saving treatments sooner due to intense, amplified …
Comprehensive palliative care improves quality of life, survival, and symptoms in thoracic cancer patients
Palliative care improves quality of life for thoracic cancer patients
This meta-analysis of 6490 people with thoracic cancer found that comprehensive palliative care interventions improved quality of life (SMD …
Comprehensive palliative care can improve survival, manage symptoms, and boost quality of life for people living with thoracic cancers.
Long-read sequencing improves detection of structural variants and methylation patterns in liquid biopsy
Long-read sequencing improves detection of cancer signals in blood
This mini-review examines the application of long-read sequencing (LRS) for liquid biopsy, specifically focusing on cfDNA and ctDNA. The aut…
Newer long-read sequencing technology helps doctors identify complex genetic changes and the source of tumors in lung, brain, and pediatric …
View Original Abstract ↓
Pancreatic cancer is a highly aggressive malignancy with a 5-year relative survival rate of only 13%. Current treatment options have limited efficacy, and mRNA vaccines offer a new direction for its treatment. However, how to accurately identify antigen targets that possess tumor specificity, functional relevance, and immunogenicity remains the key bottleneck restricting the clinical translation of mRNA vaccines for pancreatic cancer. Recent clinical studies have advanced KRAS mutant vaccines and personalized neoantigen mRNA vaccines, yet most rely on single antigens or highly individualized designs, limiting scalability and broader clinical applicability. In this systematic review, we integrated evidence from public databases and experimental studies to identify and evaluate 16 potential pancreatic cancer mRNA vaccine antigens (ADAM9, WNT7A, TMOD3, MET, EFNB2, TPX2, AGPS, OSBPL9, KDM5A, NRAS, SCP-1, GAGE, RAB5A, ANO6, CHMP2B, and PAK2). All candidates were initially selected based on aberrant tumor expression and further prioritized using stratification strategies incorporating antigen-presenting cell infiltration, immune-related cell death pathways such as ferroptosis and pyroptosis, and functional relevance to tumor progression. ADAM9 and PAK2 showed high expression in pancreatic cancer and strong associations with tumor proliferation, invasion, and immune regulation. SCP-1 and GAGE, as cancer–testis antigens, exhibited high tumor specificity and immunogenic potential. In addition, KDM5A and ANO6 may enhance antitumor efficacy through modulation of ferroptosis or pyroptosis. Nevertheless, several candidates remain constrained by normal tissue expression or limited mechanistic evidence. This review provides a stratified framework for antigen prioritization and highlights key challenges in pancreatic cancer mRNA vaccine development, offering guidance for future multi-antigen vaccine design and translational immunotherapy.
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
New Asthma Drug Cuts Attacks Without Recent Crisis
Related in Allergy & Immunology
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
FDA Approves Exdensur for Add-On Maintenance Treatment of Severe Eosinophilic Asthma
FDA approves new long-acting shot Exdensur for severe asthma.
FDA approved Exdensur (IL-5 antagonist) for add-on maintenance treatment of severe eosinophilic asthma in patients aged 12 years and older. …
The FDA approved Exdensur as an add-on treatment for severe asthma in people 12 and older. It is given as a shot every six months. This new …
CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
Immune Cells and Signaling Pathways Influence Bone Health in Osteoporosis
This narrative review synthesizes the role of CD8+ T cells and related cytokines like IFN-gamma, CCL5, and IL-33 in bone metabolism. The aut…
New research highlights how specific immune cells and signaling pathways may play a dual role in protecting or promoting bone loss in osteop…
From Other Specialties
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.